Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Quick Stats
Jun 05, 202659.8
AI Score
HOLD0.3
Volume Ratio
Jul 29, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
PFE Stock Summary
Last updated
PFE is currently trading at $26.105, positioned above its 200-day moving average of $25.85, indicating a long-term uptrend. The stock has a 52-week range of $23.08 to $28.745.
Technical Analysis: The 50-day moving average stands at $26.59, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PFE at 59.8/100 with a HOLD recommendation.
PFE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PFE Price vs Max Options Open Interest
PFE Max Change In Options Open Interest
PFE Options - Sort by Max open Interest (near term)
5th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PFE Daily Out of Money Options - Sort by Max open Interest (near term)
5th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PFE Daily In the Money Options - Sort by Max open Interest (near term)
5th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PFE Most Active Options by Volume(near term)
5th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Pfizer Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PFE Moving Averages Analysis
Pfizer Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 05, 2026
PFE (Pfizer Inc.) Simple Moving Averages
Moving Averages are last updated Jun 05, 2026
| Days | MA |
|---|---|
| 10 | 25.84 |
| 20 | 25.78 |
| 30 | 26.03 |
| 50 | 26.59 |
| 100 | 26.66 |
| 200 | 25.85 |
PFE Fundamental Analysis
| P/E (Forward) | 8.6356 |
| P/E (Trailing) | 19.3435 |
| Market Cap ($) | 144.4 billion |
| Earnings/Share ($) | 1.31 |
| Net Proft Margin (%) | 0.1183 |
| Dividend/Share ($) | 1.72 |
| EPS Estimate Current Year ($) | 2.9617 |
| EPS Estimate Next Year ($) | 2.8371 |
| WallStreet Target Price ($) | 29.1878 |
| Most Recent Quarter |
Pfizer reaches landmark agreement with U.S. government to lower drug costs for American patients, leading to surge in stock price and potential 25-50% upside. Despite past criticisms, MAGA loyalists now face unlikely partnership with Pfizer. Stock price needs to break $30 resistance for anticipated breakout.
Updated 2025-10-01 02:00:02